CL2004000732A1 - Compuestos derivados de oximas sustituidas y sus sales farmaceuticamente aceptables; procedimiento de preparacion de dichos compuestos; composicion farmaceutica que los contiene; y uso de los compuestos para el tratamiento del cancer. - Google Patents
Compuestos derivados de oximas sustituidas y sus sales farmaceuticamente aceptables; procedimiento de preparacion de dichos compuestos; composicion farmaceutica que los contiene; y uso de los compuestos para el tratamiento del cancer.Info
- Publication number
- CL2004000732A1 CL2004000732A1 CL200400732A CL2004000732A CL2004000732A1 CL 2004000732 A1 CL2004000732 A1 CL 2004000732A1 CL 200400732 A CL200400732 A CL 200400732A CL 2004000732 A CL2004000732 A CL 2004000732A CL 2004000732 A1 CL2004000732 A1 CL 2004000732A1
- Authority
- CL
- Chile
- Prior art keywords
- compounds
- pharmaceutically acceptable
- acceptable salts
- oximes
- cancer
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/38—Heterocyclic compounds having sulfur as a ring hetero atom
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/04—Antineoplastic agents specific for metastasis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
- C07D333/02—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
- C07D333/04—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom
- C07D333/26—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D333/38—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
- C07D409/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Oncology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Heterocyclic Compounds Containing Sulfur Atoms (AREA)
- Plural Heterocyclic Compounds (AREA)
Abstract
SON OBJETIVOS DE LA PRESENTE INVENCION LOS COMPUESTOS DE LA FORMULA I SUS SALES FARMACEUTICAMENTE ACEPTABLES COMO SUS FORMAS ENANTIOMERICAS, SUS DIASTEREOISOMEROS Y SUS RACEMATOS, LA OBTENCION DE LOS COMPUESTOS RECIEN MENCIONADOS, LOS MEDICAMENTOS QUE LOS CONTIENEN Y SU FABRICACION ASI COMO EL USO DE LOS COMPUESTOS RECIEN MENCIONADOS COMO INHIBIDORES DE DESACETILASA DE HISTONA (HDAC) Y POR LO TANTO PARA EL CONTROL O PREVENCION DE ENFERMEDADES Y TRANSTORNOS MENCIONADOS ANTERIORMENTE, O PARA LA FABRICACION DE LOS MEDICAMENTOS CORRESPONDIENTES.
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP03007829 | 2003-04-04 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CL2004000732A1 true CL2004000732A1 (es) | 2005-02-04 |
Family
ID=33104054
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CL200400732A CL2004000732A1 (es) | 2003-04-04 | 2004-04-02 | Compuestos derivados de oximas sustituidas y sus sales farmaceuticamente aceptables; procedimiento de preparacion de dichos compuestos; composicion farmaceutica que los contiene; y uso de los compuestos para el tratamiento del cancer. |
Country Status (14)
| Country | Link |
|---|---|
| US (1) | US7173060B2 (es) |
| EP (1) | EP1613622A1 (es) |
| JP (1) | JP2006515345A (es) |
| KR (1) | KR100733757B1 (es) |
| CN (1) | CN1771247A (es) |
| AR (1) | AR043823A1 (es) |
| AU (1) | AU2004226215A1 (es) |
| BR (1) | BRPI0409182A (es) |
| CA (1) | CA2519301A1 (es) |
| CL (1) | CL2004000732A1 (es) |
| MX (1) | MXPA05010424A (es) |
| RU (1) | RU2005133994A (es) |
| TW (1) | TW200424187A (es) |
| WO (1) | WO2004087693A1 (es) |
Families Citing this family (25)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EA007272B1 (ru) | 2002-03-13 | 2006-08-25 | Янссен Фармацевтика Н. В. | Новые ингибиторы гистондеацетилазы |
| MXPA04007776A (es) | 2002-03-13 | 2004-10-15 | Janssen Pharmaceutica Nv | Derivados de sulfonilamino como nuevos inhibidores de histona deacetilasa. |
| ATE398105T1 (de) | 2002-03-13 | 2008-07-15 | Janssen Pharmaceutica Nv | Carbonylamino- derivativate als neue inhibitoren von histone deacetylase |
| BR0307606A (pt) | 2002-03-13 | 2004-12-21 | Janssen Pharmaceutica Nv | Derivados de piperazinila, piperidinila e morfolinila como inibidores de histona desacetilase |
| SG156687A1 (en) | 2004-07-28 | 2009-11-26 | Janssen Pharmaceutica Nv | Substituted indolyl alkyl amino derivatives as novel inhibitors of histone deacetylase |
| NZ599464A (en) | 2005-02-03 | 2014-03-28 | Topotarget Uk Ltd | Combination therapies using hdac inhibitors |
| DK1901729T3 (da) | 2005-05-13 | 2012-05-14 | Topotarget Uk Ltd | Farmaceutiske formuleringer af HDAC-inhibitorer |
| EP1885710B1 (en) | 2005-05-18 | 2015-08-19 | Janssen Pharmaceutica N.V. | Substituted aminopropenyl piperidine or morpholine derivatives as novel inhibitors of histone deacetylase |
| AU2006270322A1 (en) | 2005-07-14 | 2007-01-25 | Takeda San Diego, Inc. | Histone deacetylase inhibitors |
| CA2627923C (en) | 2005-11-10 | 2016-01-12 | Topotarget Uk Limited | Histone deacetylase (hdac) inhibitors (pxdlol) for the treatment of cancer |
| CN101370803B (zh) | 2006-01-19 | 2012-12-12 | 詹森药业有限公司 | 作为组蛋白脱乙酰酶抑制剂的取代的吲哚基-烷基-氨基衍生物 |
| US8101616B2 (en) | 2006-01-19 | 2012-01-24 | Janssen Pharmaceutica N.V. | Pyridine and pyrimidine derivatives as inhibitors of histone deacetylase |
| EP1979328B1 (en) | 2006-01-19 | 2012-12-26 | Janssen Pharmaceutica N.V. | Pyridine and pyrimidine derivatives as inhibitors of histone deacetylase |
| JP5247470B2 (ja) | 2006-01-19 | 2013-07-24 | ジヤンセン・フアーマシユーチカ・ナームローゼ・フエンノートシヤツプ | ヒストンデアセチラーゼのインヒビターとしてのピリジン及びピリミジン誘導体 |
| JP5225104B2 (ja) | 2006-01-19 | 2013-07-03 | ジヤンセン・フアーマシユーチカ・ナームローゼ・フエンノートシヤツプ | 新しい、ヒストンデアセチラーゼのインヒビターとしてのアミノフェニル誘導体 |
| CN101374828B (zh) | 2006-01-19 | 2012-09-19 | 詹森药业有限公司 | 作为组蛋白脱乙酰酶抑制剂的杂环烷基衍生物 |
| CA2680838A1 (en) | 2007-03-28 | 2008-10-16 | Santen Pharmaceutical Co., Ltd. | Intraocular pressure-lowering agent comprising compound having histone deacetylase inhibitory effect as active ingredient |
| MX2010003230A (es) | 2007-09-25 | 2010-04-07 | Topotarget Uk Ltd | Metodos para la sintesis de ciertos compuestos de acido hidroxamico. |
| WO2009145989A2 (en) * | 2008-04-02 | 2009-12-03 | Amira Pharmaceuticals, Inc. | Aminoalkylphenyl antagonists of prostaglandin d2 receptors |
| WO2010010127A1 (en) | 2008-07-23 | 2010-01-28 | Novartis Ag | Sphingosine 1 phosphate receptor modulators and their use to treat muscle inflammation |
| US9265734B2 (en) | 2008-09-03 | 2016-02-23 | Biomarin Pharmaceutical Inc. | Compositions including 6-aminohexanoic acid derivatives as HDAC inhibitors |
| US8957066B2 (en) | 2011-02-28 | 2015-02-17 | Biomarin Pharmaceutical Inc. | Histone deacetylase inhibitors |
| US10059723B2 (en) | 2011-02-28 | 2018-08-28 | Biomarin Pharmaceutical Inc. | Histone deacetylase inhibitors |
| EP2680694B1 (en) | 2011-02-28 | 2019-01-02 | BioMarin Pharmaceutical Inc. | Histone deacetylase inhibitors |
| KR20150132345A (ko) | 2013-03-15 | 2015-11-25 | 바이오마린 파머수티컬 인크. | Hdac 저해제 |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| IT1033046B (it) | 1970-10-31 | 1979-07-10 | Finotto Martino | Procedimento di fabbricazione di benzimidazoli sostituiti |
| DE2201062A1 (de) * | 1972-01-11 | 1973-07-26 | Bayer Ag | N-alkoxycarbonyl- bzw. n-alkylthiocarbonyl-2-(2'-thienyl)-benzimidazole, ein verfahren zu ihrer herstellung und ihre verwendung als fungizide |
| NZ219974A (en) * | 1986-04-22 | 1989-08-29 | Goedecke Ag | N-(2'-aminophenyl)-benzamide derivatives, process for their preparation and their use in the control of neoplastic diseases |
| JPH0692398B2 (ja) * | 1987-07-07 | 1994-11-16 | 日本農薬株式会社 | ピラゾ−ルオキシム誘導体及び該化合物を含有する殺菌殺虫殺ダニ剤 |
| US6174905B1 (en) | 1996-09-30 | 2001-01-16 | Mitsui Chemicals, Inc. | Cell differentiation inducer |
| US20020103192A1 (en) | 2000-10-26 | 2002-08-01 | Curtin Michael L. | Inhibitors of histone deacetylase |
| US6784173B2 (en) * | 2001-06-15 | 2004-08-31 | Hoffmann-La Roche Inc. | Aromatic dicarboxylic acid derivatives |
| JP4641670B2 (ja) * | 2001-06-28 | 2011-03-02 | 株式会社フジタ | 水浄化構造 |
| AR034897A1 (es) | 2001-08-07 | 2004-03-24 | Hoffmann La Roche | Derivados n-monoacilados de o-fenilendiaminas, sus analogos heterociclicos de seis miembros y su uso como agentes farmaceuticos |
-
2004
- 2004-03-30 TW TW093108684A patent/TW200424187A/zh unknown
- 2004-03-31 US US10/814,410 patent/US7173060B2/en not_active Expired - Fee Related
- 2004-04-01 AR ARP040101103A patent/AR043823A1/es not_active Application Discontinuation
- 2004-04-02 BR BRPI0409182-5A patent/BRPI0409182A/pt not_active IP Right Cessation
- 2004-04-02 CL CL200400732A patent/CL2004000732A1/es unknown
- 2004-04-02 AU AU2004226215A patent/AU2004226215A1/en not_active Abandoned
- 2004-04-02 CN CNA2004800092703A patent/CN1771247A/zh active Pending
- 2004-04-02 MX MXPA05010424A patent/MXPA05010424A/es active IP Right Grant
- 2004-04-02 KR KR1020057018818A patent/KR100733757B1/ko not_active IP Right Cessation
- 2004-04-02 WO PCT/EP2004/003498 patent/WO2004087693A1/en active Application Filing
- 2004-04-02 JP JP2006500084A patent/JP2006515345A/ja active Pending
- 2004-04-02 EP EP04725309A patent/EP1613622A1/en not_active Withdrawn
- 2004-04-02 CA CA002519301A patent/CA2519301A1/en not_active Abandoned
- 2004-04-02 RU RU2005133994/04A patent/RU2005133994A/ru not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| US7173060B2 (en) | 2007-02-06 |
| RU2005133994A (ru) | 2006-06-27 |
| KR20060011947A (ko) | 2006-02-06 |
| MXPA05010424A (es) | 2005-11-04 |
| CA2519301A1 (en) | 2004-10-14 |
| WO2004087693A1 (en) | 2004-10-14 |
| EP1613622A1 (en) | 2006-01-11 |
| CN1771247A (zh) | 2006-05-10 |
| KR100733757B1 (ko) | 2007-06-29 |
| US20040214880A1 (en) | 2004-10-28 |
| AR043823A1 (es) | 2005-08-17 |
| AU2004226215A1 (en) | 2004-10-14 |
| JP2006515345A (ja) | 2006-05-25 |
| TW200424187A (en) | 2004-11-16 |
| BRPI0409182A (pt) | 2006-04-11 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CL2004000732A1 (es) | Compuestos derivados de oximas sustituidas y sus sales farmaceuticamente aceptables; procedimiento de preparacion de dichos compuestos; composicion farmaceutica que los contiene; y uso de los compuestos para el tratamiento del cancer. | |
| CL2020002511A1 (es) | Compuestos heterocíclicos como inmunomoduladores. | |
| CL2021000382A1 (es) | Compuestos novedosos de sulfonamidaurea | |
| MX2020007479A (es) | Profármacos de ketamina, composiciones y usos de los mismos. | |
| AR047922A1 (es) | Nuevos derivados de pentafluorsulfanilo, su obtencion y su utilizacion como agentes farmaceuticos | |
| UY38186A (es) | Sal sódica de n-((1,2,3,5,6,7-hexahidro-s-indacen-4-il)carbamoil)-1-isopropil-1h-pirazol-3-sulfonamida | |
| PA8675701A1 (es) | Nuevos derivados del fluoreno, composiciones que los contienen y su utilización | |
| UY28691A1 (es) | Derivados de difenilazetidona | |
| CL2007002733A1 (es) | Compuestos derivados de 2-aril-6-fenil-imidazo[1,2-a]piridinas; procedimiento de obtencion de los compuestos; composicion farmaceutica; y uso para el tratamiento y prevencion de enfermedades neurodegenerativas, osteoporosis y cancer. | |
| UY29869A1 (es) | Compuestos de benzamida | |
| CL2008000946A1 (es) | Compuestos derivados de pirrolopirimidina, inhibidores de cianasa jak3; procedimiento de preparacion; composicion farmaceutica que comprende a dicho compuesto; y uso del compuesto para el tratamiento de rechazo de transplantes, enfermedades autoinmun | |
| ECSP045004A (es) | Inhibidores de la 17beta-hidroxiesteroide deshidrogenasa tipo 3 para el tratamiento de enfermedades andrógeno dependientes | |
| HN2003000417A (es) | Intermedio de formulacion aceptablemente no higroscopico que comprende un farmaco higroscopico | |
| ECSP078052A (es) | Nuevos derivados de la 2-azetidinona como inhibidores de la absorción del colesterol para el tratamiento de condiciones hiperlipidémicas | |
| CU23464B7 (es) | (1,8)naftidirin-2-onas y compuestos relacionados para el tratamiento de la esquizofrenia | |
| ECSP088329A (es) | Nuevos diazaespiroalcanos y su uso para el tratamiento de enfermedades mediadas por ccr8 | |
| CR10304A (es) | Compuestos de tetrahidropiridotienopirimidina y procedimientos de uso de los mismos | |
| UY27882A1 (es) | Compuestos quimicos | |
| UY29613A1 (es) | Compuestos quimicos vi | |
| ECSP034811A (es) | Derivados heterocicliloxi-, -tioxi - y - aminobenzazole tales como ligandos 5-hidroxitriptamina-6 | |
| CL2007002578A1 (es) | Compuestos derivados de n-(1-ftalazin-1-il-piperidin-4-il)-amidas; composicion farmaceutica; y uso para el tratamiento y prevencion de trastornos de la fertilidad, osteoporosis y cancer. | |
| GT200600161A (es) | Nuevas combinaciones terapeuticas para el tratamiento o la prevencion de los trastornos psicoticos | |
| UY29607A1 (es) | Compuestos quimicos | |
| ECSP045353A (es) | Derivados de benzoxazinona, su preparación y aplicación como medicamentos | |
| UY28333A1 (es) | Inhibidores de caspasa y sus usos. |